蔡晓瑜, 高枫, 黄斌, 秦会平. 表观遗传修饰调控铁死亡参与慢性阻塞性肺疾病的研究进展[J]. 广西医科大学学报, 2024, 41(8): 1206-1212. DOI: 10.16190/j.cnki.45-1211/r.2024.08.015
引用本文: 蔡晓瑜, 高枫, 黄斌, 秦会平. 表观遗传修饰调控铁死亡参与慢性阻塞性肺疾病的研究进展[J]. 广西医科大学学报, 2024, 41(8): 1206-1212. DOI: 10.16190/j.cnki.45-1211/r.2024.08.015
CAI Xiaoyu, GAO Feng, HUANG Bin, QIN Huiping. Progress in epigenetic modification of ferroptosis involved in chronic obstructive pulmonary disease[J]. Journal of Guangxi Medical University, 2024, 41(8): 1206-1212. DOI: 10.16190/j.cnki.45-1211/r.2024.08.015
Citation: CAI Xiaoyu, GAO Feng, HUANG Bin, QIN Huiping. Progress in epigenetic modification of ferroptosis involved in chronic obstructive pulmonary disease[J]. Journal of Guangxi Medical University, 2024, 41(8): 1206-1212. DOI: 10.16190/j.cnki.45-1211/r.2024.08.015

表观遗传修饰调控铁死亡参与慢性阻塞性肺疾病的研究进展

Progress in epigenetic modification of ferroptosis involved in chronic obstructive pulmonary disease

  • 摘要: 铁死亡是一种特殊的细胞程序性死亡,与自噬、凋亡等死亡方式不同,通常表现为线粒体缩小、膜密度增高和嵴减少等,铁死亡的发生机制主要与细胞内铁代谢系统失调、脂质过氧化、谷胱甘肽减少有关。慢性阻塞性肺疾病(COPD)已成为威胁人类健康的主要慢性呼吸系统疾病,吸入烟草或其他大气颗粒引起的慢性炎症、氧化应激和蛋白酶/抗蛋白酶失衡等致使COPD疾病发生。表观遗传修饰通过组蛋白或核酸序列修饰影响基因的可遗传表达,调控铁死亡相关通路中基因表达以放大或抑制铁死亡在COPD中的作用,为疾病发展提供潜在治疗靶点。本文就铁死亡机制、铁死亡与COPD、表观遗传修饰调控铁死亡参与COPD发病3个方面阐述在COPD疾病发生、发展中的作用,为COPD治疗提供参考。

     

    Abstract: Ferroptosis is a special type of programmed cell death, which is different from autophagy, apoptosis and other modes of death, and characterized by mitochondrial shrinkage, membrane density increase and ridge reduction. The mechanism of ferroptosis is mainly related to the dysregulation of intracellular iron metabolism system, lipid peroxidation, and reduction of glutathione. Chronic obstructive pulmonary disease (COPD) has developed into a serious chronic respiratory disease threatening human health. Chronic inflammation, oxidative stress, and protease/antiprotease imbalance caused by inhalation of tobacco or other atmospheric particles contribute to the development of COPD. Epigenetic modifications affect the heritable expression of genes through histone or nucleic acid sequence modification, and regulate the expression of genes in the ferroptosis-related pathway to amplify or inhibit the role of ferroptosis in COPD. These modifications provide potential therapeutic targets for the disease progression. In this paper, the mechanism of ferroptosis, the relationship between ferroptosis and COPD, and epigenetic modifications regulating ferroptosis and participating in the pathogenesis of COPD are discussed in order to provide reference for the treatment of COPD.

     

/

返回文章
返回